"Designing Growth Strategies is in our DNA"

Parkinson’s Disease Drugs Market Size, Share and Industry Analysis By Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors), Route of Administration (Oral, Injection, Transdermal), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Regional Forecast, 2019 - 2026

The global parkinson’s disease drugs market size was valued at USD 4,500.0 Million in 2018, is projected to reach USD 8,383.2 Million by the end of 2026, exhibiting... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Jun, 2019 | Report ID: FBI100655 | Status : Published

 

Request for Customization

Refresh Button
Parkinson’s disease drugs Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2014-2018
  • 133
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X